Glimepiride Export Market Intelligence: India's 242 Suppliers Shipping to 94 Countries — TransData Nexus 2026

Q: Who are the top glimepiride exporters from India?

The top glimepiride exporters from India are: 1. INDOCO REMEDIES LIMITED — $46.4M (60.8% market share); 2. MICRO LABS LIMITED — $5.3M (7.0% market share); 3. IPCA LABORATORIES LIMITED — $3.6M (4.7% market share); 4. INVENTIA HEALTHCARE LIMITED — $3.0M (3.9% market share); 5. MEDREICH LIMITED — $2.3M (3.0% market share). Together they account for 79.4% of India's total glimepiride export value.

Q: What is the total export value of glimepiride from India?

The total export value of glimepiride from India is $76.3M USD, recorded across 3,159 shipment transactions from 242 active exporters to 94 destination countries. The average shipment value is $24.2K.

Q: Which countries import glimepiride from India?

India exports glimepiride to 94 countries worldwide. The top importing countries are: UNITED STATES (67.1% share, $51.2M), SOUTH AFRICA (4.8% share, $3.7M), PHILIPPINES (4.5% share, $3.4M), JAPAN (3.0% share, $2.3M), CYPRUS (1.8% share, $1.4M). These five markets account for 81.2% of total export value.

Q: What is the HS code for glimepiride exports from India?

The primary HS code for glimepiride exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of glimepiride exports from India?

The average unit price for glimepiride exports from India is $281.82 USD per unit, with prices ranging from $0.00 to $35653.63 depending on formulation, packaging, and order volume. The total market is valued at $76.3M across 3,159 shipments.

Q: Which ports handle glimepiride exports from India?

The primary ports for glimepiride exports from India are SAHAR AIR (11.1% of shipments), NHAVA SHEVA SEA (INNSA1) (8.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (7.2% of shipments), DELHI AIR (7.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of glimepiride?

India is one of the world's leading exporters of glimepiride due to its large base of 242 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports glimepiride to 94 countries, demonstrating 48% global market coverage.

Q: What certifications do Indian glimepiride exporters need?

Indian glimepiride exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import glimepiride from India?

There are 535 registered buyers importing glimepiride from India, spread across 94 countries. The repeat buyer rate is 65.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top glimepiride supplier from India?

INDOCO REMEDIES LIMITED is the leading glimepiride exporter from India with a market share of 60.8% and total export value of $46.4M across 41 shipments. The top 5 suppliers together control 79.4% of total export value.

Suresh Sormare

Glimepiride

India Pharmaceutical Trade Intelligence

$76.3M242 Suppliers94 CountriesHS 30049099

ExportsIndia → UNITED STATES67.1%India → SOUTH AFRICA4.8%

ImportsMALTA → India$43.6K GREECE → India$5.3K

#1 Supplier: INDOCO REMEDIES #1 Buyer: EVERSANA LIFE

Glimepiride Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Glimepiride to the World

Between 2022 and 2026, India exported $76.3M worth of glimepiride across 3,159 verified shipments to 94 countries — covering 48% of world markets in the Diabetes & Endocrine segment. The largest destination is UNITED STATES (67.1%). INDOCO REMEDIES LIMITED leads with a 60.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Glimepiride export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Glimepiride export data snapshot — $76.3M · 242 exporters · 94 countriesTransData Nexus · Indian Customs Data

Top Glimepiride Exporters from India

242 active exporters · Ranked by export value

View all 242 →

Top Glimepiride Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INDOCO REMEDIES LIMITED	$46.4M	41	2	60.8%
2	MICRO LABS LIMITED

Top Countries Importing Glimepiride from India

94 destination markets · Ranked by import value

All 94 countries →

Top Countries Importing Glimepiride from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$51.2M	67.1%
2	SOUTH AFRICA	$3.7M	4.8%
3	PHILIPPINES	$3.4M	4.5%
4	JAPAN	$2.3M	3.0%
5	CYPRUS	$1.4M	1.8%
6	TANZANIA	$1.3M	1.7%
7	FRANCE	$1.2M	1.5%
8	VIETNAM	$1.0M	1.3%
9	NIGERIA	$926.4K	1.2%
10	MALTA	$851.5K	1.1%

UNITED STATES is India's largest glimepiride export destination, absorbing 67.1% of total exports worth $51.2M. The top 5 importing countries — UNITED STATES, SOUTH AFRICA, PHILIPPINES, JAPAN, CYPRUS — together account for 81.2% of India's total glimepiride export value. The remaining 89 destination countries collectively receive the other 18.8%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Glimepiride to India?

8 origin countries · Total import value: $59.8K

India imports glimepiride from 8 countries with a combined import value of $59.8K. The largest supplier is MALTA ($43.6K, 8 shipments), followed by GREECE and SOUTH KOREA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Glimepiride to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	MALTA	$43.6K	8	72.9%
2	GREECE	$5.3K	12	8.9%
3	SOUTH KOREA	$5.1K	2	8.6%
4	UNITED STATES	$3.4K	4	5.7%
5	AUSTRALIA	$1.1K	2	1.8%
6	GERMANY	$992	4	1.7%
7	HUNGARY	$184	3	0.3%
8	UNITED KINGDOM	$78	1	0.1%

MALTA is the largest supplier of glimepiride to India, accounting for 72.9% of total import value. The top 5 origin countries — MALTA, GREECE, SOUTH KOREA, UNITED STATES, AUSTRALIA — together supply 97.9% of India's glimepiride imports. Click any country to see detailed supplier and buyer data for that import corridor.

Glimepiride — Export Intelligence Video

Visual overview of India's glimepiride import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's glimepiride pharmaceutical import and export market — $76.3M in total trade, 242 verified manufacturers, and 94 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Glimepiride

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Glimepiride is approved for the treatment of type 2 diabetes mellitus. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Glimepiride, indicating a competitive generic market. Notably, Avandaryl, a combination of rosiglitazone maleate and glimepiride, received FDA approval in November 2005. The substantial export volume to the U.S. underscores the importance of Indian manufacturers adhering to FDA regulations, including Good Manufacturing Practices (GMP) and the Drug Supply Chain Security Act (DSCSA). The presence of 242 active Indian exporters highlights the competitive landscape and the necessity for stringent compliance to maintain market access.

2EU & UK Regulatory Framework

In the European Union, Glimepiride is authorized for managing type 2 diabetes. The European Medicines Agency (EMA) has approved various formulations, including Amaryl, which underwent a mutual recognition procedure initiated in June 1995. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring marketing authorization and adherence to EU GMP guidelines. Manufacturers exporting to these regions must ensure compliance with these regulatory frameworks to facilitate market entry and sustain product availability.

3WHO Essential Medicines & Global Standards

Glimepiride is included in the World Health Organization's Model List of Essential Medicines, underscoring its significance in global health. The drug is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different markets. Manufacturers must comply with these standards to meet international quality requirements and facilitate global distribution.

4India Regulatory Classification

In India, Glimepiride is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing under the Drug Price Control Order (DPCO). Manufacturers intending to export Glimepiride must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The primary patents for Glimepiride have expired, leading to a robust generic market with multiple manufacturers producing the drug. This patent expiration has facilitated increased competition and accessibility, contributing to the significant export volumes from India.

6Recent Industry Developments

In May 2025, the NPPA revised the ceiling price for Glimepiride, reflecting changes in production costs and market dynamics. In August 2025, the CDSCO issued updated guidelines for the bioequivalence studies of generic Glimepiride formulations, aiming to enhance the quality and efficacy of generics. In November 2025, the EMA approved a new fixed-dose combination of Glimepiride with another antidiabetic agent, expanding treatment options for patients with type 2 diabetes. In January 2026, the FDA conducted inspections of several Indian manufacturing facilities producing Glimepiride, emphasizing the importance of compliance with GMP standards for continued market access. In March 2026, the WHO updated its Essential Medicines List, reaffirming the inclusion of Glimepiride, highlighting its ongoing relevance in global diabetes management.

These developments underscore the dynamic regulatory environment surrounding Glimepiride, necessitating continuous monitoring and compliance by manufacturers to ensure sustained market presence and adherence to international standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Glimepiride

Retail & reference prices across 9 markets vs. India FOB export price of $281.82/unit

Global Price Benchmark for Glimepiride across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, multiple generic versions of Glimepiride are approved, contributing to its affordability.
United Kingdom	$0.05	GBP	The NHS Drug Tariff lists Glimepiride, ensuring standardized pricing across the UK.
Germany	$0.06	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceutical pricing, maintaining affordability for essential medications.
Australia	$0.06

Supply Chain Risk Assessment — Glimepiride

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Glimepiride, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of India's API and KSM requirements are sourced from China, making the supply chain vulnerable to disruptions. This dependency was highlighted in December 2025 when China implemented a price reduction of 40–50% on 41 APIs and KSMs, aiming to undercut Indian manufacturers and challenge India's self-sufficiency initiatives.

The strategic control of KSMs by China poses a significant risk, as any disruption in supply can halt API production, leading to shortages of essential medications like Glimepiride. This structural dependency underscores the need for India to bolster its domestic production capabilities to mitigate such risks.

2Supplier Concentration & Single-Source Risk

The export market for Glimepiride is highly concentrated, with the top five exporters accounting for 79.4% of total exports. INDOCO REMEDIES LIMITED leads with a 60.8% share, followed by MICRO LABS LIMITED (7.0%), IPCA LABORATORIES LIMITED (4.7%), INVENTIA HEALTHCARE LIMITED (3.9%), and MEDREICH LIMITED (3.0%). This concentration increases the risk of supply disruptions, as issues affecting these key players could significantly impact global availability.

Access Complete Glimepiride Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,159 transactions across 94 markets.

Request Demo View Pricing

Frequently Asked Questions — Glimepiride Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top glimepiride exporters from India?

The leading glimepiride exporters from India are INDOCO REMEDIES LIMITED, MICRO LABS LIMITED, IPCA LABORATORIES LIMITED, and 12 others. INDOCO REMEDIES LIMITED leads with 60.8% market share ($46.4M). The top 5 suppliers together control 79.4% of total export value.

What is the total export value of glimepiride from India?

The total export value of glimepiride from India is $76.3M, recorded across 3,159 shipments from 242 active exporters to 94 countries. The average shipment value is $24.2K.

Which countries import glimepiride from India?

India exports glimepiride to 94 countries. The top importing countries are UNITED STATES (67.1%), SOUTH AFRICA (4.8%), PHILIPPINES (4.5%), JAPAN (3.0%), CYPRUS (1.8%), which together account for 81.2% of total export value.

What is the HS code for glimepiride exports from India?

The primary HS code for glimepiride exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Glimepiride

Glimepiride

Top Glimepiride Exporters from India

Top Countries Importing Glimepiride from India

Who Supplies Glimepiride to India?

Quick Facts

Related Diabetes & Endocrine

Related Analysis

Need Details?

Glimepiride — Export Intelligence Video

Regulatory Landscape — Glimepiride

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Glimepiride

Supply Chain Risk Assessment — Glimepiride

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Glimepiride Trade Intelligence

Frequently Asked Questions — Glimepiride Exports from India

Who are the top glimepiride exporters from India?

What is the total export value of glimepiride from India?

Which countries import glimepiride from India?

What is the HS code for glimepiride exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of glimepiride exports from India?

Which ports handle glimepiride exports from India?

Why is India a leading exporter of glimepiride?

What certifications do Indian glimepiride exporters need?

How many buyers import glimepiride from India?

What is the market share of the top glimepiride exporter from India?

Analysis Methodology